LSD1 emerges as a pivotal player in various tumor diseases, including breast cancer, colorectal cancer, lung cancer, and gastric cancer, where its elevated expression correlates with tumor grade, malignancy, and prognosis. The gene discussed is KDM1A; the disease is neoplasm.